Mark Finkelstein
Papers
2
Total Citations
71
H-Index
2
About
Mark Finkelstein is a urologic surgeon and researcher whose work centers on improving surgical outcomes for patients undergoing robotic and minimally invasive procedures for prostate and kidney cancers. His most influential study, a 2017 retrospective analysis of robot-assisted radical prostatectomies, demonstrated that a modified frailty index is a strong predictor of Clavien-Dindo IV complications—a finding that has shaped preoperative risk stratification and garnered 52 citations. Finkelstein also contributed to the understanding of partial nephrectomy outcomes, co-authoring a 2016 paper that compared utilization trends and three-month results across open, laparoscopic, and robotic approaches (19 citations). His research bridges the gap between patient physiology and surgical technique, emphasizing how frailty and procedural choice affect recovery and complication rates. By integrating geriatric assessment into urologic oncology, Finkelstein has helped advance personalized surgical care, making his work essential reading for clinicians and researchers focused on optimizing outcomes in high-risk populations.
Research Focus
Key Achievements
Top Papers
- 1
- 2